摘要 : The promise of precision medicine is now a clinical reality. Advances in our understanding of the molecular genetics of colorectal cancer (CRC) are leading to the development of a variety of biomarkers that are being used as early... 展开
作者 | Grady~W.M. Pritchard~C.C. |
---|---|
作者单位 | |
期刊名称 | 《Toxicologic pathology》 |
总页数 | 16 |
语种/中图分类号 | 英语 / R99 |
关键词 | biomarkers BRAF cetuximab chromosome instability colon cancer EGFR KRAS microsatellite instability MSI panitumumab. |
馆藏号 | N2007EPST0001312 |